Literature DB >> 2171617

The effect of oral salbutamol on cation transport measured in vivo in healthy volunteers.

A J Wood1, C J Brearley, J K Aronson, D G Grahame-Smith.   

Abstract

1. We have measured the effect of oral salbutamol on cation transport in vivo by studying the disposition of an oral load of rubidium chloride in healthy treated volunteers and in untreated matched controls. 2. During the administration of salbutamol there was a significantly lower plasma rubidium concentration 5 h after the administration of the oral load of rubidium chloride, reflecting an increase in the net clearance of rubidium from the plasma into at least some tissues in vivo. 3. There was no difference in either intraerythrocytic rubidium concentrations or the pseudo-rate constant for erythrocyte rubidium uptake in vivo after salbutamol. 4. Ex vivo incubation of whole blood preloaded in vivo with rubidium showed that the clearance of rubidium from the plasma was inhibited by 95% in the presence of the Na+,K(+)-ATPase inhibitor digoxin. 5. These data suggest that salbutamol stimulates cation transport via Na+,K(+)-ATPase in vivo into some tissues but not into the erythrocyte. 6. This pattern of change in rubidium disposition after salbutamol is completely different from the patterns of change we have seen in patients with essential hypertension or acute manic illness. We therefore suggest that the changes in erythrocyte rubidium uptake which we have previously described in vivo in patients with essential hypertension or acute manic illness do not result from beta 2-adrenoceptor-mediated catecholamine stimulation of Na+,K(+)-ATPase.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171617      PMCID: PMC1368140          DOI: 10.1111/j.1365-2125.1990.tb03788.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  31 in total

1.  Subsensitivity of adenylate cyclase and decreased beta-adrenergic receptor binding after chronic exposure to (minus)-isoproterenol in vitro.

Authors:  J Mickey; R Tate; R J Lefkowitz
Journal:  J Biol Chem       Date:  1975-07-25       Impact factor: 5.157

2.  Erythrocyte membrane cation carrier in mania.

Authors:  G J Naylor; D A Dick; E G Dick; E P Worrall; M Peet; P Dick; L J Boardman
Journal:  Psychol Med       Date:  1976-11       Impact factor: 7.723

3.  Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes.

Authors:  M G Caron; R J Lefkowitz
Journal:  J Biol Chem       Date:  1976-04-25       Impact factor: 5.157

4.  M.H.P.G. excretion and clinical classification in depressive disorders.

Authors:  J J Schildkraut; B A Keeler; E L Grab; J Kantrowich; E Hartmann
Journal:  Lancet       Date:  1973-06-02       Impact factor: 79.321

5.  Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrame of patients with chronic renal disease.

Authors:  C H Cole
Journal:  Clin Sci Mol Med       Date:  1973-12

6.  Erythrocyte membrane cation carrier in depressive illness.

Authors:  G J Naylor; D A Dick; E G Dick; D Le Poidevin; S F Whyte
Journal:  Psychol Med       Date:  1973-11       Impact factor: 7.723

7.  The interaction of sodium and potassium with the sodium pump in red cells.

Authors:  R P Garay; P J Garrahan
Journal:  J Physiol       Date:  1973-06       Impact factor: 5.182

8.  Daily variations of the urine content of 3-methoxy-4-hydroxyphenylglycol in two manic-depressive patients.

Authors:  P A Bond; F A Jenner; G A Sampson
Journal:  Psychol Med       Date:  1972-02       Impact factor: 7.723

9.  Catecholamine metabolism, depression and stress.

Authors:  J W Maas; H Dekirmenjian; J Fawcett
Journal:  Nature       Date:  1971-04-02       Impact factor: 49.962

10.  Abnormal leucocyte composition and sodium transport in essential hypertension.

Authors:  R P Edmondson; R D Thomas; P J Hilton; J Patrick; N F Jones
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.